Company Search:
Advanced Search
Sponsored Links
Trovagene Inc Company Snapshot
Trovagene Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Trovagene Inc with three other companies in this sector in the United States: Idera Pharmaceuticals, Inc. (2015 sales of $249,000.00 of which 100% was Novel Therapeutics), Pluristem Therapeutics Incorporation. ($379,000.00 of which 100% was Stem Cells Expansion), and AmpliPhi Biosciences Corp ($475,000.00 ).

Sales Analysis. During the year ended December of 2015, sales at Trovagene Inc were $312,812.00 . This is an increase of 11.6% versus 2014, when the company's sales were $280,178.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Trovagene Inc
  Stock Performance Chart for Trovagene Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 2.25
(Figures in U.S. Dollars)
1 Week -6.3%   13 Weeks 2.3%  
4 Weeks -47.1%   52 Weeks -53.6%  
Trovagene Inc Key Data:
  Ticker: TROV Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 312,812
(Year Ending Jan 2016).
Employees: 72
  Currency: U.S. Dollars Market Cap: 68,884,664
  Fiscal Yr Ends: December Shares Outstanding: 30,615,406
  Share Type: Common Closely Held Shares: 2,926,776
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.